Structural Basis of Type IV Pilus-Induced Clostridium difficile Microcolony Formation

IV型菌毛诱导的艰难梭菌微菌落形成的结构基础

基本信息

  • 批准号:
    9088787
  • 负责人:
  • 金额:
    $ 15.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Clostridium difficile, a spore-forming anaerobic Gram-positive bacillus, is the cause of a spectrum of gastrointestinal illness ranging from mild diarrhe though pseudomembranous colitis, and toxic megacolon. Alarmingly, the incidence, severity and mortality of C. difficile colitis have all increased significantly in the past twenty years. Th mechanism of C. difficile toxicity is well-characterized but no vaccine against C. difficile infecton exists and our knowledge about the interactions of C. difficile with its host during colonization i limited. We have shown that protein subunits of the Type IV pili of C. difficile are associated wit cellular adherence and the initiation of biofilm formation through the association of bacteria into microcolonies. Type IV Pili (T4P) are hair-like surface appendages produced by many species of pathogenic Gram negative bacteria which play a role in diverse processes such as cellular adhesion, colonization, twitching motility, biofilm formation, horizontal gene transfer and in numerous instances are essential for virulence. T4Ps are composed exclusively or primarily of many copies of pilin protein, tightly packed in a helix so that the highly hydrophobic amino-terminus of the pilin is buried in the pilus core. Although better characterized in Gram-negative bacteria, several Gram-positive bacteria, including C. difficile and C. perfringens, have now been shown to produce T4P and T4P genes have been discovered in the genomes of all members of the Clostridium genus. This project aims to characterize the structure, supramolecular assembly and role in biofilm formation of the Type IV pili of C. difficile. Current Research: I have established structural investigations into six putative pilin genes identified in the C. difficile genome and have solved the structure of two, the major pilin subunit PilA1 and a minor pilin, PilJ, by x-ray crystallography. As both of these proteins have been shown to be incorporated into the pilus fiber, I have used these two structures, in combination with data from other sources, to model the structure of a C. difficile Type IV pilus. This model is supported by mutagenesis studies of in vivo pilus assembly performed by a collaborator, Glen Armstrong. Additionally, I have grown isotopically-labeled samples of another pilin, PilA2, and have collected data using NMR spectroscopy allowing me to assign the resonances and calculate the necessary distance constraints to determine the structure by NMR. Initial studies of biofilm formation by C. difficile R202091 and strains with gene-interruptions in pilin genes show clearly that Type IV pili promote biofilm formation in vitro by increasing bacterial self-association. Assays measuring the direct binding of soluble pilin proteins to eukaryotic cells show that a minor pilin, PilJ, directly associates with HeLa, Caco-2 and gastric epithelial cells. The major pilin has a weak affinity for Caco-2 cells while other pilin proteins, including PilW, show no binding. These studies are designed to probe the hypothesis that C. difficile Type IV pili mediate the attachment of in vivo microcolonies to host cells. Independent Phase: My efforts as an independent investigator will be directed towards elucidating the role of C. difficile minor pilins in pilus assembly and biofilm formation. Due to te extreme variability of the major pilin PilA1, when compared to the minor pilins, I hypothesize that any specific protein-protein interactions mediated by Type IV pili involve minor pilins. I propose to test the ability of C. difficile mutants deficient in minor pilins to produce Type IV pili and t form biofilms in vitro. My expectation is that some of these minor pilins will produce fewer or no Type IV pili because they are required for pilus initiation but any that are pilated to wild-type levels but form biofilm at reduced levels are likely involved in specific interactions which mediat bacterial self-association. Investigations into these mechanisms will benefit from continuing investigations into the three-dimensional structures of these proteins, particularly in improving our understanding of how minor pilins are incorporated into the pilus fiber.
 描述(由申请人提供):艰难梭菌是一种产芽孢厌氧革兰氏阳性杆菌,是一系列胃肠道疾病的病因,从轻度腹泻到伪膜性结肠炎,再到中毒性巨结肠,令人震惊的是,艰难梭菌的发病率、严重程度和死亡率。过去二十年来,艰难梭菌结肠炎均显着增加。艰难梭菌毒性机制已得到充分表征。但不存在针对艰难梭菌感染的疫苗,并且我们对艰难梭菌在定植过程中与其宿主相互作用的了解有限。我们已经证明,艰难梭菌 IV 型菌毛的蛋白质亚基与细胞粘附和起始相关。通过细菌结合形成生物膜 IV 型菌毛 (T4P) 是由多种致病性革兰氏阴性菌产生的毛发状表面附属物,在细胞粘附、定植、抽搐运动、生物膜形成、水平基因转移等多种过程中发挥作用,并在许多情况下发挥作用。 T4Ps 完全或主要由许多菌毛蛋白拷贝组成,紧密地堆积在螺旋中,因此菌毛蛋白的疏水性氨基末端被埋在螺旋中。虽然在革兰氏阴性细菌中得到了更好的表征,但现在已证明包括艰难梭菌和产气荚膜梭菌在内的几种革兰氏阳性细菌可以产生 T4P,并且在梭菌属所有成员的基因组中都发现了 T4P 基因。该项目旨在表征艰难梭菌 IV 型菌毛的结构、超分子组装及其在生物膜形成中的作用。 目前的研究:我对艰难梭菌基因组中确定的六个假定菌毛蛋白基因进行了结构研究,并通过 X 射线晶体学解析了两个主要菌毛蛋白亚基 PilA1 和次要菌毛蛋白 PilJ 的结构。蛋白质已被证明融入菌毛纤维中,我使用这两种结构,结合其他来源的数据,对艰难梭菌 IV 型菌毛的结构进行建模。 得到了合作者 Glen Armstrong 进行的体内菌毛组装诱变研究的支持。此外,我还培养了另一种菌毛 PilA2 的同位素标记样品,并使用 NMR 光谱收集了数据,使我能够分配共振并计算必要的距离。对艰难梭菌 R202091 和菌毛基因中存在基因中断的菌株形成生物膜的初步研究清楚地表明,IV 型菌毛促进生物膜。测量可溶性菌毛蛋白与真核细胞的直接结合的体外形成表明,次要菌毛蛋白 PilJ 与 HeLa、Caco-2 和胃上皮细胞直接结合。主要菌毛蛋白具有弱亲和力。对于 Caco-2 细胞,而其他菌毛蛋白(包括 PilW)没有显示出结合。这些研究旨在探讨艰难梭菌 IV 型菌毛介导体内附着的假设。小集落到宿主细胞。 独立阶段:作为一名独立研究者,我的努力将致力于阐明艰难梭菌次要菌毛蛋白在菌毛组装和生物膜形成中的作用,由于主要菌毛蛋白 PilA1 与次要菌毛蛋白相比具有极大的变异性,我意识到这一点。 IV 型菌毛介导的任何特定蛋白质-蛋白质相互作用都涉及次要菌毛蛋白,我建议测试缺乏次要菌毛蛋白的艰难梭菌突变体在体外产生 IV 型菌毛和形成生物膜的能力。菌毛蛋白将产生较少或不产生 IV 型菌毛,因为它们是菌毛启动所必需的,但任何菌毛达到野生型水平但以降低水平形成生物膜的菌毛都可能涉及介导细菌的特定相互作用对这些机制的研究将受益于对这些蛋白质的三维结构的持续研究,特别是在提高我们对小菌毛蛋白如何融入菌毛纤维的理解方面。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kurt Henry Piepenbrink其他文献

Kurt Henry Piepenbrink的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kurt Henry Piepenbrink', 18)}}的其他基金

Structural Basis of Type IV Pilus-Induced Clostridium difficile Microcolony Formation
IV型菌毛诱导的艰难梭菌微菌落形成的结构基础
  • 批准号:
    9492751
  • 财政年份:
    2017
  • 资助金额:
    $ 15.34万
  • 项目类别:
Structure and Function of Type IV Pili in Clostridium difficile
艰难梭菌IV型菌毛的结构和功能
  • 批准号:
    8647642
  • 财政年份:
    2014
  • 资助金额:
    $ 15.34万
  • 项目类别:
Structure and Function of Type IV Pili in Clostridium difficile
艰难梭菌IV型菌毛的结构和功能
  • 批准号:
    8811000
  • 财政年份:
    2014
  • 资助金额:
    $ 15.34万
  • 项目类别:

相似国自然基金

基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
  • 批准号:
    72304279
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
  • 批准号:
    82373638
  • 批准年份:
    2023
  • 资助金额:
    59 万元
  • 项目类别:
    面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
  • 批准号:
    72304180
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
  • 批准号:
    82304256
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于健康行为程式模型提升高血压患者药物依从性的干预策略构建研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
靶向 1-磷酸鞘氨醇 (S1P1) 受体治疗芳香酶抑制剂引起的肌肉骨骼症状
  • 批准号:
    10668781
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
  • 批准号:
    10718260
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
Supramolecular pediatric HIV vaccine design
超分子儿科艾滋病疫苗设计
  • 批准号:
    10341039
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了